FENNEC PHARMACEUTICALS INC.
Biopharmaceutical company focused on preventing hearing loss in pediatric oncology.
FENC | US
Overview
Corporate Details
- ISIN(s):
- CA31447P1009
- LEI:
- Country:
- United States of America
- Address:
- PO BOX 13628, 27709 RESEARCH TRIANGLE PARK
- Website:
- https://fennecpharma.com/
- Sector:
- Manufacturing
Description
Fennec Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of its proprietary product, PEDMARK®. PEDMARK is a unique formulation of sodium thiosulfate designed to reduce the risk of ototoxicity (permanent hearing loss) associated with cisplatin chemotherapy. The product is specifically indicated for pediatric patients with localized, non-metastatic solid tumors. The company's core mission is to address this significant unmet medical need in pediatric oncology, preventing lifelong hearing loss in children undergoing cancer treatment.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all FENNEC PHARMACEUTICALS INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for FENNEC PHARMACEUTICALS INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for FENNEC PHARMACEUTICALS INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
